Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

DARK SECRETS: Reshma ramachandran | Vintage Vibes

FDA again bypasses advisers to remove black-box warnings from menopause treatments

Some experts express concern about ‘lack of transparency’ as agency removes warnings on three estrogen patches

The Guardian - US · Oct 30

As RFK’s lifestyle seeps into policy, some fret over long-term effect

When Health and Human Services Secretary Robert F. Kennedy Jr. took the helm of the department in February 2025, he pledged to remove special interests from HHS and chart a new path focused on “gold-standard science.” He made his core policy interests clear in November 2024, even before he was President…

Roll Call · May 15

Top-down approach has Congress AWOL on FDA, experts say - Roll Call

Since President Donald Trump took office, the FDA has lost about 20 percent of its staff through reduction-in-force efforts.

Roll Call · Jan 8

From analysis to the latest developments in health,
read the most diverse news in one place.

Judge temporarily blocks agencies from removing health data - Roll Call

Doctors for America sued after the removal of several webpages, including guidance related to STIs and HIV.

Roll Call · Feb 11, 2025

RFK Jr will cut prescription drugs and increase weed and psychedelics access

Trump’s health department pick has expressed distrust of pharmaceuticals and attacked ‘suppression of psychedelics’

The Guardian - US · Nov 25, 2024

Chevron doctrine ruling a ‘gut-punch’ for US health and environment – experts

Decision that overturned convention of deference to federal agencies could upend regulations on tobacco, drugs and medical bills

The Guardian - US · Jul 6, 2024

Gene therapy for muscular dystrophy stirs hopes and controversy

The FDA is considering greenlighting the experimental treatment under its accelerated approvals program. Some critics point out the therapy isn't yet proven to work and may be costly.

WEKU · May 2, 2023

Read news from The Economist, FT, and more,
with one subscription

FDA has new leverage over companies looking for a quicker drug approval

The Food and Drug Administration has new tools to hold drug companies accountable for promises they make about medications. But the agency has yet to show its hand in using this new power.

WEKU · Mar 3, 2023

Speedier drug approvals hit slowdown as FDA faces scrutiny

The Food and Drug Administration is slowing its use of a pathway that expedites the approval of promising drugs

The Independent UK · Dec 7, 2022

Read Why Pfizer Is Limiting Supply Of Paxlovid For Combination Studies: Bloomberg

Amid rising concerns over the potential development of resistance to Pfizer Inc's (NYSE:PFE) COVID-19 pill Paxlovid, the company has declined to supply researchers with the antiviral for use in combination studies, according to a Bloomberg report. Researchers say that Paxlovid combined with other drugs might stave off resistance. Pfizer hasn't started any combination…

Benzinga · May 19, 2022

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

646 stories

PFE

359 stories

Health and Human Services

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.